VCYT VERACYTE
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 15 analyst firms say about VERACYTE: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
15 rated views · 16 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8075
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8048
Recent analyst activity · last 90 days
Our tracked history has 8 reports on VCYT from 6 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 2 lowered it and 2 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: Needham lowered its target from $69.00 (set 15 Sep 2026) to $46.00 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Canaccord Genuity | Kyle Mikson | Hold | 3 Aug 2026 | 50.00 USD |
| Craig-Hallum | William B Bonello | Buy | 16 Jul 2026 | 45.00 USD |
| Freedom Capital Markets | Keith Hinton | Buy | 15 Sep 2026 | 66.00 USD |
| Guggenheim | Subbu Nambi | Buy | 29 Jun 2026 | 65.00 USD |
| Jefferies | Tycho Peterson | Buy | 13 Apr 2026 | Conflicting reports · excluded |
| Leerink Partners | Puneet Souda | Buy | 17 Sep 2026 | 55.00 USD |
| Morgan Stanley | Tejas Savant | Sell | 4 Aug 2026 | 44.00 USD |
| Needham | Mike Matson | Buy | 15 Sep 2026 | 69.00 USD |
| Piper Sandler | David Westenberg | Buy | 4 Aug 2026 | 54.00 USD |
| Stephens | Mason Carrico | Buy | 4 Aug 2026 | 55.00 USD |
| UBS | Doug Schenkel | Buy | 9 Sep 2026 | 65.00 USD |
| UBS | Lu Li | Buy | 9 Sep 2026 | 65.00 USD |
| Weiss Ratings | Unnamed analyst | — | 24 Sep 2026 | — |
| William Blair | Matt Larew | Buy | 3 Jul 2026 | — |
| Wolfe Research | Mike Polark | Buy | 1 Jun 2026 | 63.00 USD |
| Data feed RESEARCH | Research Team | Hold | 2 Oct 2026 | 48.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:45 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.